SCHWARTZ MARK W. 4
4 · Galena Biopharma, Inc. · Filed Jan 17, 2012
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2012-01-12+200,000→ 200,000 totalExercise: $0.72Exp: 2022-01-12→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Granted pursuant to the Issuer's 2007 Incentive Plan.
- [F2]The options will vest in equal quarterly installments of 12,500 shares for four years beginning on April 12, 2012, with all such options being fully vested on January 12, 2016.